Back to mobile site
Get it on Google Play

FDA grants breakthrough designation to EMD Serono's lupus drug enpatoran

July 8, 2026 8:00 AM EDT Send to a Friend
EMD Serono, the U.S. and Canada healthcare unit of Merck KGaA, Darmstadt, Germany, announced that the U.S. Food and Drug ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login